Andrology in China: current status and 10 years' progress.
about
Preclinical pharmacokinetics of TPN729MA, a novel PDE5 inhibitor, and prediction of its human pharmacokinetics using a PBPK model.Low-frequency germline variants across 6p22.2-6p21.33 are associated with non-obstructive azoospermia in Han Chinese men.An association study of HFE gene mutation with idiopathic male infertility in the Chinese Han population.Scientific publications in andrology journals from Chinese authors in various parts of East Asia: a 10-year survey of the literature.
P2860
Andrology in China: current status and 10 years' progress.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Andrology in China: current status and 10 years' progress.
@en
Andrology in China: current status and 10 years' progress.
@nl
type
label
Andrology in China: current status and 10 years' progress.
@en
Andrology in China: current status and 10 years' progress.
@nl
prefLabel
Andrology in China: current status and 10 years' progress.
@en
Andrology in China: current status and 10 years' progress.
@nl
P2093
P2860
P356
P1476
Andrology in China: current status and 10 years' progress.
@en
P2093
Ji-Chuan Zhu
Qing-Quan Xu
Xiao-Feng Wang
Yong-Ping Zhao
P2860
P304
P356
10.1038/AJA.2010.123
P577
2011-06-06T00:00:00Z